tiprankstipranks
Neuphoria Therapeutics (NEUP)
NASDAQ:NEUP
NEUP
Neuphoria Therapeutics
RESEARCH TOOLSreports
Want to see NEUP full AI Analyst Report?

Neuphoria Therapeutics (NEUP) Revenue

300 Followers
StatisticsMarket CapRevenue

Neuphoria Therapeutics Revenue

Neuphoria Therapeutics had a revenue of 0.00 in the quarter ending Mar 31, 2026, with ―. This bring the company's revenue in the last twelve months to -10.47M, Increased -171.83%. In the fiscal year ending Jun 30, 2025, Neuphoria Therapeutics had annual revenue of 15.65M with Infinity% growth.
Revenue (ttm)
-10.47M
Revenue Growth
―
P/S Ratio
1.83
Revenue/Employee
$1,956,181
Employees
8
Market Cap
$28.70M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Jun 30, 2025
15.65M―+∞%
Jun 30, 2024
―――
Jun 30, 2023
―-263.61K-100.00%
Jun 30, 2022
263.61K―+∞%
Jun 30, 2021
―-32.06K-100.00%
Jun 30, 2020
32.06K-2.65M-98.80%
Jun 30, 2019
2.68M-78.86K-2.86%
Jun 30, 2018
2.76M-1.37M-33.25%
Jun 30, 2017
4.13M――